Pinto Shelly 4

What Happened

• Shelly Pinto, SVP, Finance and CAO of ALX Oncology (ALXO), sold 565 shares in an open-market/private sale on 2026-02-18 at $2.27 per share, totaling about $1,283. The filing indicates the shares were sold to satisfy tax withholding related to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date and price: 2026-02-18 — 565 shares sold at $2.27 each.
• Total proceeds: Approximately $1,283.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnote: Sale was to satisfy tax obligations on RSU vesting (footnote F1).
• Filing date: 2026-02-20 — appears to have been filed within the usual 2-business-day Form 4 window.

Context

• This sale was a tax-withholding sale tied to RSU vesting, a common administrative transaction that does not necessarily indicate the insider’s view of the company. The dollar amount is small relative to most executive transactions, and no purchase/option exercise or gift was reported.